Therapeutic Potential of Human Chorionic Gonadotropin Against Painful Bladder Syndrome/Interstitial Cystitis.

Abstract

Painful bladder syndrome/interstitial cystitis is a debilitating chronic bladder disease that primarily affects women. The disease is due to a damage of urothelial cell lining. As a result, potassium particles and other toxic substances in urine can leak into bladder mucosa, causing the symptoms of lower abdominal/pelvic discomfort, pain, increased urination frequency, urgency, nocturia, and so on, all of which can substantially reduce the quality of daily life. There are multiple symptom reliving therapies. Among them, only pentosan polysulfate sodium, sold under the brand name of Elmiron, has been approved for oral use by US Food and Drug Administration. It provides the relief after several months of use. Based on the scientific leads presented in this article, we propose that human chorionic gonadotropin has a therapeutic potential that is worth investigating for the treatment of this disease.

• Authors: C V Rao
• Journal: Reproductive sciences (Thousand Oaks, Calif.) (Reprod Sci) Vol. 23 Issue 11 Pg. 1451-1458 (11 2016) ISSN: 1933-7205 [Electronic] United States
• PMID: 27004802 (Publication Type: Journal Article, Review)
• Copyright: © The Author(s) 2016.

Chemical References

• Chorionic Gonadotropin
• Pentosan Sulfuric Polyester

Topics

• Animals
• Chorionic Gonadotropin (therapeutic use)
• Cystitis, Interstitial (therapy)
• Female
• Humans
• Male
• Pentosan Sulfuric Polyester (therapeutic use)
• Urinary Bladder (physiopathology)